子宫丸治疗新疆维族妇女HPV亚临床感染宫颈病变患者的临床研究  

Clinical observation of the external Chinese medicine Zigongwan on treatment for cervical subclinical human papillomavirus infection of Uygur women

作　　者：岳明明[1] 葛崇华[1] 洪玉[2] 

机构地区：[1]新疆医科大学附属中医医院妇科,新疆乌鲁木齐830000 [2]杭州师范大学健康管理学院

出　　处：《中国妇幼保健》2013年第26期4391-4393,共3页Maternal and Child Health Care of China

基　　金：新疆医科大学校级课题〔XJC201070〕

摘　　要：目的:观察外用中药子宫丸治疗新疆维族患者宫颈人乳头瘤病毒(HPV)亚临床感染的临床疗效。方法:对符合纳入标准的40例随机分成两组,分别以子宫丸奥平栓宫颈上药治疗,观察治疗前后临床症状、人乳头瘤病毒量的变化。结果:子宫丸组对HPV-DNA病毒负荷量及临床症状体征有效率分别为76.19%和76.19%。奥平栓组对HPV-DNA病毒负荷量及临床症状体征有效率分别为81.82%和77.27%。结论:子宫丸和奥平栓都能有效治疗宫颈HPV亚临床感染,使HPV-DNA含量下降,临床症状体征改善。Objective： To observe the effect of the external application Chinese medicine Zigongwan on the treatment for cervical subclinical human papillomavirus infection of Uygur and explore its mechanism. Methods： 40 patienls who met the inclusion criteria were randomly divided into two groups. Patients were treated with external application medicine treatment wilh Zigongwan and Recombinant Human Interferon c^2a in Suppositol＇y Form （1FNc~ -2b） respectively. Clinical symptom, viral load of HPV variation were observed. Results： HPV DNA viral load and clinical symptoms and signs in Zigongwan group were respectively 76. 19% , 76. 19%. They were respectiw＇ly 81.82ck , 77.27% in group of lFNct - 2b. Conclusion ： Zigongwan and IFNct - 2b all can be effective on cervical HPV infection, viral load of HPV - DNA decreased, the clinical symptoms improved.

关 键 词：宫颈病变 中药疗法 人乳头状瘤病毒 重组人干扰素 维吾尔族 

分 类 号：R711.32[医药卫生—妇产科学]